| Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19 S Notarbartolo, V Ranzani, A Bandera, P Gruarin, V Bevilacqua, ... Science immunology 6 (62), eabg5021, 2021 | 161 | 2021 |
| Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity A Bianco, V Reghellin, L Donnici, S Fenu, R Alvarez, C Baruffa, F Peri, ... PLoS pathogens 8 (3), e1002576, 2012 | 136 | 2012 |
| Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion V Fumagalli, M Ravà, D Marotta, P Di Lucia, C Laura, E Sala, M Grillo, ... Science Immunology 7 (67), eabl9929, 2021 | 79 | 2021 |
| COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models A Conforti, E Marra, F Palombo, G Roscilli, M Ravà, V Fumagalli, A Muzi, ... Molecular Therapy 30 (1), 311-326, 2022 | 66 | 2022 |
| Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study A Lombardi, GM Butta, L Donnici, G Bozzi, M Oggioni, P Bono, M Matera, ... The Lancet Regional Health–Europe 13, 2022 | 55 | 2022 |
| Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells L Donnici, E Tiraboschi, D Tardito, L Musazzi, G Racagni, M Popoli BMC neuroscience 9, 1-13, 2008 | 38 | 2008 |
| NS5A Inhibitors Impair NS5A–Phosphatidylinositol 4-Kinase IIIα Complex Formation and Cause a Decrease of Phosphatidylinositol 4-Phosphate and Cholesterol Levels in Hepatitis C … V Reghellin, L Donnici, S Fenu, V Berno, V Calabrese, M Pagani, ... Antimicrobial agents and chemotherapy 58 (12), 7128-7140, 2014 | 33 | 2014 |
| Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody JL Torres, G Ozorowski, E Andreano, H Liu, J Copps, G Piccini, L Donnici, ... Proceedings of the National Academy of Sciences 119 (20), e2120976119, 2022 | 31 | 2022 |
| Anatomy of Omicron BA. 1 and BA. 2 neutralizing antibodies in COVID-19 mRNA vaccinees E Andreano, I Paciello, S Marchese, L Donnici, G Pierleoni, G Piccini, ... Nature communications 13 (1), 3375, 2022 | 25 | 2022 |
| DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic A Villa, E Brunialti, J Dellavedova, C Meda, M Rebecchi, M Conti, ... Pharmacological research 175, 105982, 2022 | 25 | 2022 |
| B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response E Andreano, I Paciello, G Pierleoni, G Piccini, V Abbiento, G Antonelli, ... Nature Communications 14 (1), 53, 2023 | 19 | 2023 |
| Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses V Fumagalli, P Di Lucia, M Ravà, D Marotta, E Bono, S Grassi, L Donnici, ... EMBO molecular medicine 15 (5), e17580, 2023 | 18 | 2023 |
| Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C S De Nicola, P Dongiovanni, A Aghemo, C Cheroni, R D'Ambrosio, ... PloS one 9 (8), e106022, 2014 | 16 | 2014 |
| Hepatitis C virus deletion mutants are found in individuals chronically infected with genotype 1 hepatitis C virus in association with age, high viral load and liver … C Cheroni, L Donnici, A Aghemo, F Balistreri, A Bianco, V Zanoni, ... PLoS One 10 (9), e0138546, 2015 | 14 | 2015 |
| Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination V Fumagalli, M Ravà, D Marotta, P Di Lucia, EB Bono, L Giustini, ... Nature Immunology 25 (4), 633-643, 2024 | 11 | 2024 |
| COVID-19 mRNA third dose induces a unique hybrid immunity-like antibody response E Andreano, I Paciello, G Pierleoni, G Piccini, V Abbiento, G Antonelli, ... BioRxiv, 2022.05. 09.491201, 2022 | 11 | 2022 |
| Interferon‐inducible phospholipids govern IFITM3‐dependent endosomal antiviral immunity G Unali, G Crivicich, I Pagani, M Abou‐Alezz, F Folchini, E Valeri, ... The EMBO Journal 42 (10), e112234, 2023 | 9 | 2023 |
| Nanoparticle‐mediated suicide gene therapy for triple negative breast cancer treatment L Salvioni, S Zuppone, F Andreata, M Monieri, S Mazzucchelli, C Di Carlo, ... Advanced Therapeutics 3 (8), 2000007, 2020 | 7 | 2020 |
| NS5A inhibitors impair NS5A-PI4KIIIalpha complex formation and cause a decrease of PI4P and cholesterol levels in HCV-associated membranes V Reghellin, L Donnici, S Fenu, V Berno, V Calabrese, M Pagani, ... Antimicrob. Agents Chemother 58, 7128-7140, 2014 | 7 | 2014 |
| Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 A Miluzio, A Cuomo, C Cordiglieri, L Donnici, E Pesce, M Bombaci, ... EBioMedicine 87, 2023 | 6 | 2023 |
